ID: ALA2335382

Max Phase: Preclinical

Molecular Formula: C14H20N4O

Molecular Weight: 260.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1c(=O)n(C)c2cc(N3CCCCC3)c(N)cc21

Standard InChI:  InChI=1S/C14H20N4O/c1-16-12-8-10(15)11(18-6-4-3-5-7-18)9-13(12)17(2)14(16)19/h8-9H,3-7,15H2,1-2H3

Standard InChI Key:  ZOMSUTGXSSYGLG-UHFFFAOYSA-N

Associated Targets(Human)

S-100 protein beta chain 30 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 260.34Molecular Weight (Monoisotopic): 260.1637AlogP: 1.45#Rotatable Bonds: 1
Polar Surface Area: 56.19Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.92CX LogP: 1.36CX LogD: 1.36
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.79Np Likeness Score: -0.95

References

1. Yoshimura C, Miyafusa T, Tsumoto K..  (2013)  Identification of small-molecule inhibitors of the human S100B-p53 interaction and evaluation of their activity in human melanoma cells.,  21  (5): [PMID:23375094] [10.1016/j.bmc.2012.12.042]

Source